These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35383860)
1. [Corrigendum] SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis Chen F; Lu Z; Deng J; Han X; Bai J; Liu Q; Xi Y; Zheng J Oncol Rep; 2022 May; 47(5):. PubMed ID: 35383860 [TBL] [Abstract][Full Text] [Related]
2. [Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT‑related genes Snail and E‑cadherin. Qiu Y; Liu Y; Li WH; Zhang HQ; Tian XX; Fang WG Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 38963043 [TBL] [Abstract][Full Text] [Related]
3. [Corrigendum] Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis. Xie H; Zhao J; Wan J; Zhao J; Wang Q; Yang X; Yang W; Lin P; Yu X Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799194 [TBL] [Abstract][Full Text] [Related]
4. [Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression. Cai C; He H; Duan X; Wu W; Mai Z; Zhang T; Fan J; Deng T; Zhong W; Liu Y; Zhong W; Zeng G Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825583 [TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancer. Xu Y; Liu X; Zhang H; Zhu Z; Wu X; Wu X; Li S; Song L; Xu X Oncol Rep; 2022 May; 47(5):. PubMed ID: 35322866 [TBL] [Abstract][Full Text] [Related]
6. [Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway. Shu X; Liu H; Zhen R; Jie Y; Chen L; Qi H; Wang C; Wang R; Chen D; Ran Y Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37350398 [TBL] [Abstract][Full Text] [Related]
7. [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer. Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X Int J Oncol; 2024 Nov; 65(5):. PubMed ID: 39329219 [TBL] [Abstract][Full Text] [Related]
8. [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Ji J; Shen I; Li Y; Liu Y; Shang Z; Niu Y Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477123 [TBL] [Abstract][Full Text] [Related]
9. [Corrigendum] Nogo‑B promotes the epithelial‑mesenchymal transition in HeLa cervical cancer cells via Fibulin‑5. Xiao W; Zhou S; Xu H; Li H; He G; Liu Y; Qi Y Oncol Rep; 2022 May; 47(5):. PubMed ID: 35348187 [TBL] [Abstract][Full Text] [Related]
10. [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway. Jin F; Wang H; Li D; Fang C; Li W; Shi Q; Diao Y; Ding Z; Dai X; Tao L; Sunagawa M; Wu F; Qian Y; Liu Y Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35147201 [TBL] [Abstract][Full Text] [Related]
11. [Corrigendum] RON and c‑Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells. Yin B; Liu Z; Wang Y; Wang X; Liu W; Yu P; Duan X; Liu C; Chen Y; Zhang Y; Pan X; Yao H; Liao Z; Tao Z Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004460 [TBL] [Abstract][Full Text] [Related]
12. [Corrigendum] Ski prevents TGF‑β‑induced EMT and cell invasion by repressing SMAD‑dependent signaling in non‑small cell lung cancer. Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT Oncol Rep; 2021 Feb; 45(2):787-788. PubMed ID: 33416110 [TBL] [Abstract][Full Text] [Related]
13. [Corrigendum) RNA interference‑mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin‑induced apoptosis dependent on JNK activation. He M; Sun HG; Hao JY; Li YL; Yu JK; Yan YY; Zhao L; Li N; Wang Y; Bai XF; Yu ZJ; Zheng ZH; Mi XY; Wang EH; Wei MJ Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35543152 [TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] Induction of microRNA‑let‑7a inhibits lung adeno-carcinoma cell growth by regulating cyclin D1. Zhao W; Hu JX; Hao RM; Zhang Q; Guo JQ; Li YJ; Xie N; Liu LY; Wang PY; Zhang C; Xie SY Oncol Rep; 2024 May; 51(5):. PubMed ID: 38456515 [TBL] [Abstract][Full Text] [Related]
15. [Corrigendum] miR‑490‑5p regulates the proliferation, migration, invasion and epithelial‑mesenchymal transition of pharyngolaryngeal cancer cells by targeting mitogen‑activated protein kinase kinase kinase 9. Abdeyrim A; Cheng X; Lian M; Tan Y Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35383861 [TBL] [Abstract][Full Text] [Related]
16. [Corrigendum] MicroRNA‑10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer. Xiao H; Li H; Yu G; Xiao W; Hu J; Tang K; Zeng J; He W; Zeng G; Ye Z; Xu H Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35642686 [TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial‑to‑mesenchymal transition via suppressing the ROS/ERK/Slug/E‑cadherin pathway. Zhao Z; Sun YS; Chen W; Lv LX; Li YQ Oncol Rep; 2024 Oct; 52(4):. PubMed ID: 39129320 [TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway. Kou B; Liu W; Zhao W; Duan P; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36734273 [TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro. Ji CX; Fan YH; Xu F; Lv SG; Ye MH; Wu MJ; Zh XG; Wu L Oncol Rep; 2020 Nov; 44(5):2317-2318. PubMed ID: 33000270 [TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] MicroRNA‑378 enhances migration and invasion in cervical cancer by directly targeting autophagy‑related protein 12. Tan D; Zhou C; Han S; Hou X; Kang S; Zhang Y Mol Med Rep; 2025 Jan; 31(1):. PubMed ID: 39422024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]